Portal Hypertension in Patients with Hemophilia

Overview

Journal Semin Intervent Radiol

Specialty Radiology

Date 2023 Aug 14

PMID 37575345

Authors

Dan F Laney Iv

Matthew Houle

Leigh Deshotels

Hector Ferral

Affiliations

Soon will be listed here.

References

Singh R, Clarkston W, Zuckerman D, Joist J, Bacon B . Transjugular intrahepatic portosystemic shunt for palliation of bleeding esophageal varices in a patient with severe hemophilia A, advanced HIV infection, and cirrhosis. Am J Gastroenterol. 1993; 88(12):2112-4. View

Berntorp E, Shapiro A . Modern haemophilia care. Lancet. 2012; 379(9824):1447-56. DOI: 10.1016/S0140-6736(11)61139-2. View

Makris M, Preston F, Triger D, Underwood J, Choo Q, Kuo G . Hepatitis C antibody and chronic liver disease in haemophilia. Lancet. 1990; 335(8698):1117-9. DOI: 10.1016/0140-6736(90)91124-s. View

Goedert J, Eyster M, Lederman M, Mandalaki T, Moerloose P, White 2nd G . End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood. 2002; 100(5):1584-9. View

Beirne J, Bloom A, Bass N, Kerlan Jr R, Wilson M, Gordon R . Safety and efficacy of TIPS in patients with hemophilia and cirrhosis. J Vasc Interv Radiol. 2007; 18(2):309-12. DOI: 10.1016/j.jvir.2006.12.731. View

Garcia-Pagan J, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A . Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010; 362(25):2370-9. DOI: 10.1056/NEJMoa0910102. View

Giansily-Blaizot M, Schved J . Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date. Ther Adv Hematol. 2017; 8(12):345-352. PMC: 5703115. DOI: 10.1177/2040620717737701. View

Schimpf K, Mannucci P, Kreutz W, Brackmann H, Auerswald G, Ciavarella N . Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med. 1987; 316(15):918-22. DOI: 10.1056/NEJM198704093161505. View

Berntorp E, Fischer K, Hart D, Mancuso M, Stephensen D, Shapiro A . Haemophilia. Nat Rev Dis Primers. 2021; 7(1):45. DOI: 10.1038/s41572-021-00278-x. View

10.

Stonebraker J, Bolton-Maggs P, Soucie J, Walker I, Brooker M . A study of variations in the reported haemophilia A prevalence around the world. Haemophilia. 2009; 16(1):20-32. DOI: 10.1111/j.1365-2516.2009.02127.x. View

11.

Qvigstad C, Tait R, Rauchensteiner S, Berntorp E, Moerloose P, Schutgens R . The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment. Medicine (Baltimore). 2018; 97(39):e12551. PMC: 6181599. DOI: 10.1097/MD.0000000000012551. View